Duvortuxizumab
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E[1].
Product Specifications
CAS Number
[1831098-91-9]
Product Name Alternative
MGD 011
UNSPSC
12352203
Target
CD19; CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/duvortuxizumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Duvortuxizumab]
Molecular Weight
(145.012 kDa)
References & Citations
[1]Duvortuxizumab. IMGT.|[2]Liu L, et al., MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clin Cancer Res. 2017 Mar 15;23 (6) :1506-1518.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1253093-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Signal transduction protein MDG1 (MDG1)
Ask
View Details 
MBS1253093-02 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Signal transduction protein MDG1 (MDG1)
Ask
View Details 
MBS1253093-03 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Signal transduction protein MDG1 (MDG1)
Ask
View Details 
MBS1253093-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Signal transduction protein MDG1 (MDG1)
Ask
View Details MBS1253093-05 0.02 mg (Baculovirus)
Recombinant Saccharomyces cerevisiae Signal transduction protein MDG1 (MDG1)
Ask
View Details